Novartis is a pharmaceutical company based in Basel, Switzerland. It develops and sells prescription medicines, with major areas including cancer treatments, heart and circulation medicines, and drugs for the nervous system and eye conditions. Its customers are hospitals, doctors, pharmacies and patients in many countries around the world. The company also has a generics business that supplies lower-cost copies of medicines. Novartis carries out research and manufacturing across several regions and sells its products through its own commercial teams and partners.
Novartis AG trades under the code 0QLR on the London Exchange in UK, with its price quoted in pounds sterling (GBP). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
The first paragraph was written with AI from general knowledge about the company and checked automatically; the second comes from our own data. It can contain mistakes: check the company's own website and filings before relying on it.
Market X-Ray · price-based
Strong price profile
Ranks #424 of 3787 on the London Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendFair
62/100
Mixed trend against its averages.
See the numbers →
Above 200-day average3.3%
From 52-week high-5.2%
MomentumFair
58/100
Typical recent returns for this exchange.
See the numbers →
3-month return-1.5%
6-month return7.3%
12-month, skipping last month12.8%
Risk (lower is better)Strong
83/100
Calmer than most: low volatility and shallow drawdowns.
See the numbers →
Volatility (1 year)22.4%
Worst drawdown (1 year)-15.4%
LiquidityStrong
90/100
Trades actively.
See the numbers →
Avg daily value traded128.01M GBP
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends4
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 97.10 – 132.64Daily closes, split-adjusted
Signals
50-day average121.26
200-day average120.66
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)2.62
Technical summary
Daily
Strongly bullish
12 bullish · 1 neutral · 3 bearish
Weekly
Strongly bullish
10 bullish · 1 neutral · 1 bearish
Monthly
Strongly bullish
7 bullish · 1 neutral · 0 bearish
Moving averages (daily)
SMA 10
120.8
Bullish
EMA 10
121.6
Bullish
SMA 20
119.8
Bullish
EMA 20
120.5
Bullish
SMA 50
121.3
Bullish
EMA 50
120.8
Bullish
SMA 100
122.2
Bullish
EMA 100
120.9
Bullish
SMA 200
120.7
Bullish
EMA 200
118.3
Bullish
Oscillators (daily)
RSI (14)
62.90
Neutral
MACD (12, 26)
0.85
Bullish
Momentum (12)
4.85
Bullish
Stochastic %K (14)
88.77
Bearish
Williams %R (14)
-11.23
Bearish
CCI (20)
169.7
Bearish
Pivot points (classic, last session)
S3
123.1
S2
123.5
S1
124.1
Pivot
124.5
R1
125.0
R2
125.4
R3
126.0
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Dividends
Paid, last 12 months
0.00 GBX
Yield on today's price
–
Frequency
None in the last year
Next ex-dividend date
Not announced
Ex-dividend date
Amount per share
10 Mar 2025
0.0350
7 Mar 2024
0.0330
9 Mar 2023
0.0303
8 Mar 2022
0.0294
4 Mar 2021
0.0284
3 Mar 2020
0.0280
4 Mar 2019
0.0239
Ex-dividend dates and amounts from EODHD. Shown as declared, before tax.
Prices are end-of-day closes in GBP. Educational only, not financial advice.